# PROUD-PV (NCT01949805)

> Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01949805
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: AOP Orphan Pharmaceuticals AG
- Conditions: Polycythemia Vera
- Interventions: Peg-P-IFN-alpha-2b (AOP2014); Hydroxyurea
- Enrollment: 257
- Primary outcome: Disease response rate

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 24
- Podcasts: 12
- X threads: 3

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=proud-pv-nct01949805

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01949805", "email": "<work email>"}; the inbox owner confirms by the emailed link.